Lee Hye-yeon, CEO of Mara Nanotech, challenges the implementation of personalized medical care by commercializing diagnostic platforms after 28 years of research on nanobiotechnology.
Read the full article
http://news.heraldcorp.com/view.php?ud=20180921000394
2018.09.23 | Herald Corporation
Lee Hye-yeon, CEO of Mara Nanotech, challenges the implementation of personalized medical care by commercializing diagnostic platforms after 28 years of research on nanobiotechnology.
Read the full article
http://news.heraldcorp.com/view.php?ud=20180921000394
2018.09.23 | Herald Corporation